Not applicableStudy completedNCT02125695What this trial is testingPilot Tape Harvesting StudyWho this might be right forAtopic DermatitisHealthyDiscoid Lupus Erythematosus+1 more Biogen 37
Early research (Phase 1)Ended earlyNCT01389895What this trial is testingSafety Study of AMG 557 in Subjects With Subacute Cutaneous Lupus ErythematosusWho this might be right forCutaneous LupusLupus Amgen 1
Not applicableStudy completedNCT01923415What this trial is testingA Non-drug Study Profiling Cutaneous LupusWho this might be right forLupus Erythematosus, CutaneousLupus Erythematosus, SystemicLupus Erythematosus, Discoid Janssen Research & Development, LLC 29
Testing effectiveness (Phase 2)Study completedNCT01300208What this trial is testingTo Evaluate the Preliminary Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of CC-11050 in Subjects With Discoid Lupus Erythematosus and Subacute Cutaneous Lupus ErythematosusWho this might be right forCutaneous Lupus Erythematosus Amgen 48
Large-scale testing (Phase 3)Not Yet RecruitingNCT07332481What this trial is testingEnpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic DiseaseWho this might be right forSystemic Lupus Erythematosus (SLE)Cutaneous Lupus Erythematosus (CLE) Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany 202
Testing effectiveness (Phase 2)Study completedNCT04781816What this trial is testingProof of Concept Study of SAR443122 in Patients With Cutaneous Lupus ErythematosusWho this might be right forCutaneous Lupus Erythematosus Sanofi 78
Large-scale testing (Phase 3)Looking for participantsNCT05531565What this trial is testingA 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus ErythematosusWho this might be right forSubacute Cutaneous Lupus ErythematosusChronic Cutaneous Lupus Erythematosus Biogen 474
Testing effectiveness (Phase 2)Study completedNCT05162586What this trial is testingThe WILLOW Study With M5049 in SLE and CLE (SCLE and/or DLE) (WILLOW)Who this might be right forSystemic Lupus Erythematosus EMD Serono Research & Development Institute, Inc. 456
Testing effectiveness (Phase 2)Study completedNCT01294774What this trial is testingSafety and Efficacy of KRP203 in Subacute Cutaneous Lupus ErythematosusWho this might be right forSubacute Cutaneous Lupus Erythematosus Novartis Pharmaceuticals 10
Testing effectiveness (Phase 2)Looking for participantsNCT06980805What this trial is testingAssess the Safety, Tolerability, and Efficacy of IMVT-1402 in Participants With Cutaneous Lupus Erythematosus (CLE)Who this might be right forSubacute Cutaneous Lupus ErythematosusChronic Cutaneous Lupus Erythematosus Immunovant Sciences GmbH 56
Not applicableStudy completedNCT02034344What this trial is testingSkin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy VolunteersWho this might be right forLupus Erythematosus, CutaneousLupus Erythematosus, SystemicLupus Erythematosus, Discoid+1 more Janssen Research & Development, LLC 77
Testing effectiveness (Phase 2)Active Not RecruitingNCT04857034What this trial is testingEvaluate Efficacy and Safety of Deucravacitinib in Participants With Active Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE)Who this might be right forLupus Erythematosus, DiscoidLupus Erythematosus, Subacute Cutaneous Bristol-Myers Squibb 74
Testing effectiveness (Phase 2)Ended earlyNCT01407679What this trial is testingEfficacy and Safety of Oral Alitretinoin (Toctino®) in the Treatment of Patients With Cutaneous Lupus ErythematosusWho this might be right forLupus Erythematosus, Cutaneous University Hospital Muenster 7
Large-scale testing (Phase 3)Not Yet RecruitingNCT07355218What this trial is testingEnpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)Who this might be right forSystematic Lupus ErythematosusCutaneous Lupus Erythematosus Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany 202
Large-scale testing (Phase 3)Enrolling By InvitationNCT06044337What this trial is testingA Long-Term Extension Study to Learn More About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus ErythematosusWho this might be right forSubacute Cutaneous Lupus ErythematosusChronic Cutaneous Lupus Erythematosus Biogen 322
Large-scale testing (Phase 3)Looking for participantsNCT06015737What this trial is testingA Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus ErythematosusWho this might be right forCutaneous Lupus Erythematosus AstraZeneca 302
Not applicableWithdrawnNCT00222183What this trial is testingCutaneous Lupus Erythematosus and ElidelWho this might be right forLupus Erythematosus, CutaneousLupus Erythematosus, Discoid University of Leipzig
Testing effectiveness (Phase 2)Active Not RecruitingNCT05540327What this trial is testingThe Willow LTE Study With M5049 in Participants With SCLE, DLE and/or SLE (WILLOW LTE)Who this might be right forSystemic Lupus Erythematosus Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany 379
Post-approval studies (Phase 4)Looking for participantsNCT06875960What this trial is testingContinue the Administration of Deucravacitinib in Participants With Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Who Have Completed Study IM011074 or Study IM011132Who this might be right forSystemic Lupus Erythematosus (SLE)Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Bristol-Myers Squibb 35
Early research (Phase 1)Looking for participantsNCT06013995What this trial is testingInvestigate the Safety, Tolerability, Drug Levels and Drug Effects of BMS-986326 in Adult Participants With Different Forms of LupusWho this might be right forLupus Bristol-Myers Squibb 44